CDER’s latest proposal to withdraw the accelerated acceptance of Makena (HPC) was primarily based on a large randomized trial that failed to verify the advantage of this drug to newborns or lessen the risk of PTB. https://owainpqii924429.wonderkingwiki.com/826866/the_5_second_trick_for_mkena